News | Treatment Planning | November 05, 2015

RayStation will be extended to include treatment planning for the TomoTherapy and CyberKnife systems

Accuray, RaySearch, collaboration agreement, treatment planning support, TomoTherapy, CyberKnife, radiation therapy

RayStation image courtesy of RaySearch Laboratories AB


November 5, 2015 — Accuray Inc. and RaySearch Laboratories AB announced an expansion on their existing relationship with the signing of a new long-term collaboration agreement for the integration of treatment planning support for the TomoTherapy and CyberKnife systems in the RayStation treatment planning system (TPS).

Accuray and RaySearch previously announced a long-term collaboration regarding the RayCare oncology information system.

Under the contract, Accuray will have the opportunity to offer RayStation to clinicians who use the TomoTherapy and CyberKnife system product portfolios. Current RayStation users report that the software provides multiple benefits including advanced treatment planning tools, leading workflow support, and an excellent user experience, all of which enhance treatment delivery flexibility within a radiation oncology department.

Accuray has an installed base of more than 500 TomoTherapy Systems and more than 300 CyberKnife Systems worldwide. Treatment planning support for TomoTherapy Systems in RayStation is targeted for release during 2016 and support for CyberKnife Systems for release during 2017.

The CyberKnife M6 Series robotic full-body radiosurgery system enables precise, high-quality, high-dose distributions to the patient with extreme accuracy over a minimum number of treatments, reducing side effects and preserving patients' quality of life. The TomoTherapy H Series efficiently enables physicians to customize treatment plans for the entire range of radiation therapy patients and disease types. Its design enables treatment plans to be delivered with integrated, daily computed tomography (CT) image guidance, enhancing accuracy and delivering highly precise, intensity-modulated radiation for optimal sparing of healthy tissue and critical structures.

For more information: www.accuray.com, www.raysearchlabs.com


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now